| TTM
|
12/31/2025
|
|
|---|---|---|
| Total Revenue
|
10,780.1780 | 8,260.0190 |
| Cost of Revenue
|
-149.0410 | -96.5240 |
|
Gross Profit
|
10,631.1370 | 8,163.4950 |
| Selling, General and Administrative Expenses
|
-4,506.2740 | -2,645.8820 |
|
Operating Income/Expenses
|
-4,508.5410 | -2,645.8820 |
|
Total Operating Profit/Loss
|
6,122.5960 | 5,517.6130 |
| Total Net Finance Income/Expense
|
-89.2760 | -46.9810 |
| Net Investment Income
|
20.2520 | 51.7040 |
| Irregular Income/Expenses
|
-2,070 | -2,070 |
|
Non-Operating Income/Expenses, Total
|
-2,138.3950 | -2,065.2770 |
|
Pretax Income
|
3,984.2010 | 3,452.3360 |
| Provision for Income Tax
|
-1,450 | -1,450 |
|
Net Income from Continuing Operations
|
1,753.5610 | 2,002.3360 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
1,753.5610 | 2,002.3360 |
|
Net Income after Non-Controlling/Minority Interests
|
1,753.5610 | 2,002.3360 |
|
Net Income Available to Common Stockholders
|
1,753.5610 | 2,002.3360 |
|
Diluted Net Income Available to Common Stockholders
|
1,753.5610 | 2,002.3360 |
| Basic EPS
|
0.04 | 0.05 |
| Diluted EPS
|
0.04 | 0.05 |
|
Basic Weighted Average Shares Outstanding
|
45,301.6250 | 37,715.0050 |
|
Diluted Weighted Average Shares Outstanding
|
45,301.6250 | 37,715.0050 |
| Income Statement, Supplemental
|
||
|
EBIT
|
4,073.4770 | 3,499.3170 |
|
EBITDA
|
4,328.7850 | 3,595.8410 |
|
Normalized EBITDA
|
7,261.5040 | 5,832.5080 |
|
Normalized Income
|
4,246.3722 | 3,903.5030 |
|
Total Unusual Items
|
2,932.7190 | 2,236.6670 |
|
Total Unusual Items Excluding Goodwill
|
2,932.7190 | 2,236.6670 |
|
Tax Effect of Unusual Items
|
439.9079 | 335.5001 |
|
Tax Rate, Calculated
|
0.15 | 0.15 |
12/31/2025 - 11/12/2025
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade
